For the Inventor, By the Inventor

Enter assignee name

Redwood City, CA, United States of America

Genapsys, Inc.

Calculating rank

USPTO Granted Patents = 30

CIPO Patents = 2

EPO Patents = 9

Trademarks = 1

Forward Citations = 389

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Hesaam Esfandyarpour (26 out of 35 patents)

Kosar Baghbani Parizi (17 out of 17 patents)

Mark F Oldham (16 out of 122 patents)

4. Eric S Nordman (11 out of 65 patents)

5. Susanne Baumhueter (9 out of 9 patents)

6. Cheryl Heiner (9 out of 35 patents)

7. Frank Lee (9 out of 21 patents)

8. Richard T Reel (9 out of 53 patents)

9. Meysam R Barmi (5 out of 5 patents)

10. Seth Stern (5 out of 8 patents)

11. Hamid Reza Rategh (4 out of 12 patents)

12. Paul M Kenney (3 out of 13 patents)

13. Florian Oberstrass (3 out of 24 patents)

14. Kambiz Kaviani (2 out of 35 patents)

15. Amirhossein Samakar (2 out of 4 patents)

Core Competencies:

Nucleic Acid Amplification

Electronic Sequencing

Microfluidic Devices

Biological Analysis

Genetic Analysis

Automated Reusable Reactions

Sample Preparation

Biological Species Detection

High Efficiency Sequencing

Nanoreactor System

30 patents: Sort by Forward Citations

1. 11332778 - Methods and systems for nucleic acid amplification (2022-05-17),

2. 11286522 - Systems and methods for high efficiency electronic sequencing and detection (2022-03-29),

3. 11155865 - Systems and methods for genetic and biological analysis (2021-10-26),

4. 11021748 - Systems and methods for genetic and biological analysis (2021-06-01),

5. 11015219 - Systems and methods for detection and analysis of biological species (2021-05-25),

6. 10900075 - Systems and methods for nucleic acid sequencing (2021-01-26),

7. 10787705 - Systems and methods for genetic and biological analysis (2020-09-29),

8. 10683389 - Beads for nucleic acid sequencing (2020-06-16),

9. 10612091 - Systems and methods for genetic and biological analysis (2020-04-07),

10. 10570449 - Systems and methods for biological analysis (2020-02-25),

11. 10544456 - Systems and methods for nucleic acid sequencing (2020-01-28),

12. 10533218 - Methods and systems for nucleic acid amplification (2020-01-14),

13. 10494672 - Systems and methods for genetic and biological analysis (2019-12-03),

14. 10472674 - Systems and methods for automated reusable parallel biological reactions (2019-11-12),

15. 10413900 - Microfluidic devices, systems and methods for sample preparation and analysis (2019-09-17),

Company Overview

Genapsys, Inc. is a biotechnology company based in Redwood City, California, specializing in innovative genomic sequencing technologies. The company focuses on developing advanced platforms that enable rapid and cost-effective DNA sequencing, aiming to enhance research capabilities in genomics and personalized medicine. By leveraging cutting-edge technology, Genapsys seeks to make genomic data more accessible and actionable for researchers and healthcare providers, thereby contributing to advancements in various fields, including diagnostics and therapeutics.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

30 Patents

#68 in Redwood City, CA

#2,692 in California

#11,299 in US

#21,955 in the World

Redwood City, CA, United States of America

Genapsys, Inc.

Forward Citations = 389

21 inventors:

Hesaam Esfandyarpour (26 out of 35 patents)

Kosar Baghbani Parizi (17 out of 17 patents)

Mark F Oldham (16 out of 122 patents)

4. Eric S Nordman (11 out of 65 patents)

5. Susanne Baumhueter (9 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genapsys, Inc.. Retrieved from https://idiyas.com/company/genapsys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…